DIA: Driving Insights to Action

EuroMeeting Preview: Real-World Data + AI = Clinical Evidence?

March 1, 2017

Using social media and artificial intelligence (AI) in health care product development presents opportunities and challenges to regulatory systems and professionals in the EU. “The use of artificial intelligence, in terms of deep learning tools but also automation and things like that, is an area in the making, and there are a number of companies which are involved in these kind of tools and trying to adapt them to use in the pharmaceutical and clinical environment,” explains Dr. Joseph Scheeren, Senior Vice President, Head Regulatory Affairs, Pharma and Consumer Health, Bayer Consumer Care, Switzerland. “We will see a high flight of these tools in order to help us to further generate real-world evidence for the use of medical evidence questions.” In this exclusive podcast, Dr. Scheeren further explores this topic and previews the Major European Regulatory Science Challenges DIAmond session which he will co-chair at the DIA EuroMeeting 2017 in Glasgow, Scotland. Register for our DIA EuroMeeting 2017 today!

Podbean App

Play this podcast on Podbean App